Related content

Growth hormone dose in growth hormone-deficient adults is not associated with IGF-1 gene polymorphisms

By Meyer Silke   Schaefer Stephan   Ivan Diana   Stolk Lisette   Arp Pascal   Uitterlinden Andréé G   Nawroth Peter P   Plööckinger Ursula   Stalla Güünter K   Tuschy Ulrich   Weber Matthias M   Weise Alexander   Pfüützner Andreas   Kann Peter H  

Pharmacogenomics, Vol. 10, Iss. 2, 2009-02 ,pp. : 293-302

Future Medicine

Access to resources Recommend Favorite

Clinical applications of recombinant human growth hormone in adults

By Iglesias P.   Díez J.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 1, 1999-11 ,pp. : 97-107

Informa Healthcare

Access to resources Recommend Favorite

Effects of growth hormone deficiency and rhGH replacement therapy on the 6β-hydroxycortisol/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children

By Sinués Blanca   Mayayo Esteban   Fanlo Ana   JR Esteban   Bernal María   Bocos Pilar   Bello Elena   Labarta Jose   Ferrández-Longás Angel  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 8, 2004-10 ,pp. : 559-564

Springer Publishing Company

Access to resources Recommend Favorite

Recombinant Full-Length Parathyroid Hormone (1-84)

By Moen Marit D.   Scott Lesley J.  

Drugs, Vol. 66, Iss. 18, 2006-01 ,pp. : 2371-2381

Adis International

Access to resources Recommend Favorite

Recombinant Full-Length Parathyroid Hormone (1-84): A Viewpoint by James Whitfield

By Whitfield James  

Drugs, Vol. 66, Iss. 18, 2006-01 ,pp. : 2382-2385

Adis International

Access to resources Recommend Favorite